Mupirocin is stronger than Neosporin against the bacteria that cause most skin infections. In a head-to-head clinical trial for MRSA decolonization, mupirocin cleared the bacteria in 64.8% of patients at 48 hours, compared to just 30.6% for a polysporin/bacitracin regimen. That performance gap reflects a real difference in how these two antibiotics work and what they’re designed to do.
What Each One Actually Does
Neosporin is a triple-antibiotic ointment you can buy without a prescription. It combines three ingredients: neomycin, polymyxin B, and bacitracin. Together, they cover a broad range of bacteria, including both gram-positive organisms (like staph and strep) and some gram-negative ones. The idea is to cast a wide net for minor cuts, scrapes, and burns.
Mupirocin (sold as Bactroban) is a prescription-only antibiotic with a narrower but more powerful focus. It has high-level activity against the gram-positive bacteria that cause the vast majority of skin infections: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, and other strep species. It works by blocking a specific enzyme bacteria need to build proteins, which effectively shuts down their ability to grow and reproduce. This targeted mechanism makes it exceptionally potent against staph and strep, even strains that resist other antibiotics.
MRSA Is Where the Gap Is Clearest
Methicillin-resistant Staphylococcus aureus, or MRSA, is a staph strain that shrugs off many common antibiotics. Mupirocin is recognized as the most widely used topical antibiotic in the world for treating MRSA, particularly in cases of impetigo. Neosporin’s components simply aren’t effective enough against MRSA to serve as a reliable treatment.
In a double-blind, randomized controlled trial where all patients also received antiseptic body washes, mupirocin cleared MRSA from all tested body sites in about 65% of patients within 48 hours. The polysporin arm (bacitracin plus polymyxin B, similar to Neosporin’s backbone) managed only about 31%. That’s roughly half the effectiveness for the same infection.
Why Mupirocin Requires a Prescription
Mupirocin’s potency is exactly why it stays behind the pharmacy counter. The FDA approved it specifically for treating impetigo caused by S. aureus and Streptococcus pyogenes. Keeping it prescription-only helps limit unnecessary use, because resistance to mupirocin is already climbing. A systematic review of global data found that about 7.6% of all S. aureus isolates and 13.8% of MRSA isolates now show some level of mupirocin resistance, with rates increasing over time. Widespread over-the-counter availability would likely accelerate that trend and erode one of the few effective topical options for serious staph infections.
For Minor Wounds, the Difference Shrinks
If you’re treating a clean, shallow cut or scrape at home, mupirocin’s extra potency may not matter much. Research published by the American Academy of Family Physicians found that neither mupirocin nor Neosporin improved healing times for clean surgical wounds compared to plain petroleum-based ointments. In one blinded trial of over 1,800 wounds, mupirocin showed no healing benefit at all for clean postexcisional skin wounds. A separate trial comparing Neosporin to a basic healing ointment (Aquaphor) for wounds after skin lesion removal found no difference in redness, swelling, crusting, or scabbing.
The takeaway: for a minor wound that isn’t infected, both products mainly just keep the area moist and protected. A simple petroleum jelly works about as well for that purpose, without the risk of antibiotic resistance or allergic reactions.
Neosporin’s Allergy Problem
One area where Neosporin actually performs worse than you’d expect is allergic contact dermatitis. Neomycin, one of its three active ingredients, is a well-known skin allergen. A large meta-analysis found that about 3.2% of adults and 4.3% of children with dermatitis test positive for neomycin allergy. In North America specifically, the rates are higher: 6.4% of adults and 8.1% of children. That means if you apply Neosporin to a wound and notice increasing redness, itching, or a spreading rash, there’s a real chance the ointment itself is causing the reaction rather than helping.
Mupirocin rarely causes contact allergy. Its most common side effects are mild burning or stinging at the application site, which typically resolves quickly.
When Each One Makes Sense
For everyday minor cuts, scrapes, and small burns that show no signs of infection, Neosporin or even plain petroleum jelly is a reasonable first step. The wound is likely to heal fine on its own as long as you keep it clean and covered.
Mupirocin fills a different role. It’s the go-to choice when a skin infection is already present, particularly when staph or strep bacteria are suspected. The CDC’s treatment guidelines for impetigo recommend topical mupirocin (or retapamulin) when there are only a few lesions, with oral antibiotics reserved for more widespread cases. If your doctor suspects MRSA or you have a wound that’s getting redder, warmer, or producing pus despite basic care, mupirocin is the more appropriate tool.
In short, mupirocin is the stronger antibiotic for the bacteria that matter most in skin infections. But “stronger” doesn’t always mean “better for your situation.” For a paper cut, it’s overkill. For an infected wound or impetigo, it’s the standard of care for good reason.